Waldenstrom Macroglobulinemia

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

Loncastuximab Tesirine in WM

Ibrutinib + Venetoclax in Untreated WM

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia

Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia

Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia